title: Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
authors.forename: Michael L
authors.initials: ML
authors.lastname: Bentley
authors.forename: Frank H
authors.initials: FH
authors.lastname: Biscardi
authors.forename: Christian
authors.initials: C
authors.lastname: Butcher
authors.forename: Alexander
authors.initials: A
authors.lastname: Levitov
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous / Q000009:adverse effects; D008133:Long QT Syndrome / Q000139:chemically induced; D008508:Medication Errors; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone